About 55,595 results

ALLMedicine™ Type 1 Diabetes Center

Research & Reviews  16,969 results

Hybrid Closed Loop Overcomes the Impact of Missed or Suboptimal Meal Boluses on Glucose...
Diabetes Technology & Therapeutics; Coutant R, Bismuth E et. al.

Mar 18th, 2023 - Background It is unclear whether hybrid closed-loop therapy (HCL) attenuates the metabolic impact of missed or suboptimal meal insulin bolus compared with sensor-augmented pump therapy (SAP) in children with type 1 diabetes in free-living conditio...

Relationship between serum fibroblast growth factor 19 and vascular endothelial growth ...
BMC Pediatrics; Zhang Y, Li G et. al.

Mar 18th, 2023 - Fibroblast growth factor 19 (FGF19) takes part in maintaining the balance of glycolipids and may be involved in complications of type 1 diabetes(T1D) in children. This study aimed at at evaluating the relationship among the levels of serum FGF19 a...

Use of Continuous Glucose Monitors in low- and middle-income countries: A scoping review.
Diabetic Medicine : a Journal of the British Diabetic Ass... Bernabe-Ortiz A, Carrillo-Larco RM et. al.

Mar 18th, 2023 - The use of continuous glucose monitors (CGMs) has been shown to have positive impact on diabetes management for people with type 1 diabetes (T1DM), type 2 diabetes (T2DM), and gestational diabetes (GDM) in high-income countries. However, as useful...

Diabetes Technology & Therapeutics; Dodesini AR, Borella ND et. al.

Mar 18th, 2023 - for Letter to Editor is not required.

Psychometric properties of an innovative smartphone application to investigate the dail...
PloS One; Søholm U, Broadley M et. al.

Mar 18th, 2023 - The aim of this study was to determine the acceptability and psychometric properties of the Hypo-METRICS (Hypoglycemia MEasurement, ThResholds and ImpaCtS) application (app): a novel tool designed to assess the direct impact of symptomatic and asy...

see more →

Guidelines  21 results

Management of Individuals With Diabetes at High Risk for Hypoglycemia: An Endocrine Soc...
The Journal of Clinical Endocrinology and Metabolism; McCall AL, Lieb DC et. al.

Dec 9th, 2022 - Hypoglycemia in people with diabetes is common, especially in those taking medications such as insulin and sulfonylureas (SU) that place them at higher risk. Hypoglycemia is associated with distress in those with diabetes and their families, medic...

American Association of Clinical Endocrinology Clinical Practice Guideline: Developing ...
Endocrine Practice : Official Journal of the American Col... Blonde L, Umpierrez GE et. al.

Aug 14th, 2022 - The objective of this clinical practice guideline is to provide updated and new evidence-based recommendations for the comprehensive care of persons with diabetes mellitus to clinicians, diabetes-care teams, other health care professionals and sta...

Could the development of COVID-19 vaccine-induced type 1 diabetes be explained by a simple mechanism?
Diabetes & Metabolism; Sasaki H, Itoh A et. al.

Jul 3rd, 2022 - To the Editor We read with great interest the article “Fulminant type 1 diabetes (T1DM) after Covid-19 vaccination” by Tang et al. in this journal [1]. The authors examined islet autoantibodies, HLA alleles, and the capacity for insulin secreti...

Fulminant type 1 diabetes after COVID-19 vaccination
Diabetes & Metabolism; Tang X, He B et. al.

Mar 23rd, 2022 - To the editor, The ongoing pandemic of coronavirus 2019 disease (COVID-19) has led to an unprecedented acceleration of anti-COVID-19 vaccine development. Here we report the first case of fulminant type 1 diabetes mellitus (FT1DM) with complete ...

Nutritional Recommendations for People with Type 1 Diabetes Mellitus.
Experimental and Clinical Endocrinology & Diabetes : Offi... Rubin D, Bosy-Westphal A et. al.

Dec 30th, 2020 - Nutritional Recommendations for People with Type 1 Diabetes Mellitus.|2020|Rubin D,Bosy-Westphal A,Kabisch S,Kronsbein P,Simon MC,|blood,diet therapy,methods,standards,physiology,methods,standards,physiology,

see more →

Drugs  444 results see all →

Clinicaltrials.gov  2,366 results

iACT for Eating Disorders in Type 1 Diabetes

Mar 16th, 2023 - This project is a randomized controlled trial of iACT, a novel mHealth intervention for eating disorders in type 1 diabetes (ED-T1DM). Participants will be 128 T1DM patients between the ages of 16-45 with binge-purge EDs, including threshold and s...

BEAD-T1D: Building the Evidence to Address Disparities in Type 1 Diabetes

Mar 13th, 2023 - As diabetes technologies have become more innovative and effective in the management of pediatric type 1 diabetes (T1D), research and usage has preferentially increased only in those of higher socioeconomic status (SES). Studies have consistently ...

The Importance of Sleep for Diabetes Associated Tasks and Outcomes

Mar 10th, 2023 - Background: Adolescents with type 1 diabetes (T1D) experience more disturbed sleep compared to their healthy peers, and there is some evidence that they spend less time in deep sleep, which is the most restoring part of sleep. Disturbed sleep may ...

Safety and Effectiveness of the MiniMed™ 780G System With DS5 CGM

Mar 10th, 2023 - This study is a multi-center, single arm study in insulin-requiring adult and pediatric subjects with type 1 diabetes on the MiniMed 780G system using DS5 as well as Medtronic Extended infusion set and reservoir. The run-in period and study period...

ADvanced Hybrid Closed Loop Study in Adult Population With Type 1 Diabetes

Mar 9th, 2023 - This study is a pre-market, multi-center, prospective, open label, adaptative, randomized controlled trial in insulin-requiring adult subjects with type 1 diabetes on MDI therapy. The study will have three period: Run-in Phase: The Run-in period i...

see more →

News  2,363 results

Another Artificial Pancreas a Success in Tots With Type 1 Diabetes

Mar 15th, 2023 - Very young children with type 1 diabetes saw glycemic benefits when using a hybrid closed-loop system, the randomized PEDAP trial showed. Among 102 children ages 2 to 5 years, the mean percentage of time that the glucose level was within the targe...

Why Does Insulin Cost So Much? Big Pharma Isn't the Only Player Driving Prices

Mar 12th, 2023 - Eli Lilly & Co.'s announcement that it is slashing prices for its major insulin products could make life easier for some diabetes patients while easing pressure on Big Pharma. It also casts light on the profiteering methods of the drug industry's ...

Are High Costs of Newer Diabetes Drugs Deterring Eligible Patients?

Feb 27th, 2023 - Fewer than 10% of eligible U.S. patients with type 2 diabetes used a GLP-1 receptor agonist or SGLT2 inhibitor, according to nationally representative data. While it was estimated that 22.4 million U.S. adults with diagnosed type 2 diabetes met th...

Calcium Channel Blocker Preserves Some Beta Cell Function in Early T1D

Feb 24th, 2023 - A calcium channel blocker helped to partially preserve stimulated C-peptide secretion in kids with newly diagnosed type 1 diabetes, although more intensive management did not, according to a randomized clinical trial. Children and adolescents who ...

Dexcom G7 CGM Covered by Medicare; T1D Off-Label Drug Use; Another Tepezza Lawsuit

Feb 21st, 2023 - Dexcom announced that its G7 continuous glucose monitoring (CGM) system is now available to all Medicare patients with diabetes who meet the eligibility criteria, following the system launch last week. Half of kids ages 5 and under don't eat a dai...

see more →

Patient Education  75 results see all →